File: public-information-fr-b-be-17-bvw1.pdfTrial reference: A phase II study evaluating the efficacy and the safety of first-line chemotherapy combined with TG4010 and nivolumab in patients with advanced non-squamous Non-Small-Cell Lung Cancer (NSCLC) Doc type: Information for the public
